FG
CVET

Formula Growth’s Covetrus, Inc. Common Stock CVET Stock Holding History

Formula Growth’s Portfolio CVET Stock Details CVET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-275,000
Closed -$3.27M – 154
2019
Q3 		$3.27M Buy
+275,000
New +$5.09M 0.49% 55

Other funds holding CVET

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FCM
Freshford Capital Management Rye Brook, New York $200M AUM 31.49% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Formula Growth's CVET Position: Q4 2019 in Review

Formula Growth sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2019, closing a stake of 275,000 shares — an estimated $3.27M sold.

Formula Growth first reported a position in CVET in Q3 2019 and held it in 1 quarter. The position peaked at $3.27M in Q3 2019. 265 funds tracked by Wall St. Rank hold CVET as of Q4 2019.

  • Formula Growth reported no remaining Covetrus, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Formula Growth sold 275,000 Covetrus, Inc. Common Stock shares in Q4 2019, an estimated $3.27M.
  • Formula Growth first reported a position in Covetrus, Inc. Common Stock in Q3 2019 and held it in 1 quarter.
  • Formula Growth's Covetrus, Inc. Common Stock position peaked at $3.27M in Q3 2019.
  • 265 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2019.

Based on Formula Growth's 13F filing for Q4 2019, filed 13 Feb 2020.